American Well Corporation

AMWL • Medical - Healthcare Information Services

$13.20

▲ +0.87 (+7.06%)

Current price

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$202.47M

Growth

-16.8%

Cash Flow

0/5

Trend

Negative

Evidence

Manageable debt level · 0.02Healthy liquidity · 3.37Negative growth trendWeak profitability

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:18 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$13.20

Change7.06%

Shares Out16.76M

Market Cap$202.47M

Enterprise Value$6.53M

52W Range3.71 - 14.15

Beta1.70

P/E-2.59

P/S0.93

P/B0.92

P/FCF-7.67

EV/Sales0.03

Price$13.20

Change7.06%

Shares Out16.76M

Market Cap$202.47M

Enterprise Value$6.53M

52W Range3.71 - 14.15

Beta1.70

P/E-2.59

P/S0.93

P/B0.92

P/FCF-7.67

EV/Sales0.03

EV/EBITDA-0.15

EV/FCF-0.25

Earnings Yield-38.58%

FCF Yield-13.04%

Dividend Yield0.00%

Gross Margin53.29%

Oper. Margin-42.22%

Profit Margin-38.38%

Debt/Eq0.02

Current Ratio3.37

Quick Ratio3.35

Revenue 5Y-16.77%

Target$13.00

Target Upside-1.52%

Target Median$12.50

Target Range11.00 - 16.00

Volume453.95K

Avg Volume113.77K

EPS Surprise-0.01

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

76/100

Growth Potential

Revenue and expansion

20/100

Price Attractiveness

Cheap or expensive today

95/100

Why this score▼

Manageable debt level · 0.02Healthy liquidity · 3.37Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

AMWL

Analyst sentiment

Based on 15 analyst votes · 2026-10-20

67/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-08-06

Low

$5.00

Mean

$10.50

Median

$11.00

High

$16.00

Company Overview

IPO: 9/17/2020

Industry: Medical - Healthcare Information Services

P/B i: 0.92

Debt / Equity i: 0.02

Operating Margin: -42.22%

Net Margin: -38.38%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.02

Current Ratio: 3.37

Quick Ratio: 3.35

Status: Good

Insider Transactions

Recent executive and insider activity

Gotlib Phyllis

Transaction: 07/01/2026

SELL

Change

-6,677

Price

$9.33

Filing

07/01/2026

Type

SELL

Zamansky Dmitry

Transaction: 07/01/2026

SELL

Change

-8,460

Price

$9.33

Filing

07/01/2026

Type

SELL

HIRSCHHORN MARK

Transaction: 07/01/2026

SELL

Change

-4,299

Price

$9.33

Filing

07/01/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Gotlib Phyllis	SELL	-6,677	$9.33	07/01/2026	07/01/2026
Zamansky Dmitry	SELL	-8,460	$9.33	07/01/2026	07/01/2026
HIRSCHHORN MARK	SELL	-4,299	$9.33	07/01/2026	07/01/2026
McNeice Paul Francis	SELL	-653	$9.33	07/01/2026	07/01/2026
Jackson Deborah C	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Schlegel Stephen J.	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Goldwasser Rivka	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Ross Derek	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Webb Robert Thomas	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Cosgrove Delos M.	BUY	+14,501	Not reported	06/16/2026	06/18/2026
Schlegel Stephen J.	SELL	-9,750	$8.76	06/11/2026	06/15/2026
Schoenberg Ido	BUY	+670	$7.37	05/07/2026	05/11/2026
McNeice Paul Francis	SELL	-383	$5.30	04/01/2026	04/02/2026
Zamansky Dmitry	SELL	-5,575	$5.30	04/01/2026	04/02/2026
Gotlib Phyllis	SELL	-3,706	$5.30	04/01/2026	04/02/2026
McNeice Paul Francis	BUY	+8,066	Not reported	03/04/2026	03/06/2026
Zamansky Dmitry	BUY	+50,413	Not reported	03/04/2026	03/06/2026
Gotlib Phyllis	BUY	+50,413	Not reported	03/04/2026	03/06/2026
HIRSCHHORN MARK	BUY	+50,413	Not reported	03/04/2026	03/06/2026
McNeice Paul Francis	SELL	-130	$5.24	03/02/2026	03/03/2026

About the Company

American Well Corporation

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Source - link

Peers

ADVM ALXO ATYR BMEA CAMP DTIL EUDA GUTS IMUX RPTX

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs

BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health's use of SilverCloud® by Amwell® to deliver a fully funded digital mental health benefit in South Africa. The case study examines the three questions health plans ask of digital care: whether members will use it, whether it improves their health, and what it does to costs.

GlobeNewsWire

Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?

Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.

Zacks Investment Research

A Look at American Well Corp (AMWL) After 3.4% Gain -- GF Value $6.30 vs Price $13.58

On September 30, 2026, American Well Corp (AMWL) shares rose 3.4% to $13.58, continuing a strong upward trend over the past month, where the stock has appreciat

GuruFocus

American Well Corporation (AMWL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha

Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?

Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.

Zacks Investment Research

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-05	-0.77	-0.78	-0.01
2026-02-12	-1.59	-1.43	0.16
2025-11-04	-1.45681	-1.74	-0.28319
2025-08-05	-1.84	-1.24	0.6
2025-05-01	-3.09	-1.73	1.36
2025-02-12	-3.04	-2.77	0.27
2024-10-30	-3.32	-2.87	0.45
2024-07-31	-3.94	-3.36	0.58
2024-05-01	-3.6	-5	-1.4
2024-02-14	-3.8	-3.4	0.4
2023-11-01	-4	-4	0
2023-08-02	-4.2	-4.6	-0.4